drug store, pharmacy, chain drug store, drugstore, community pharmacy, drug chain, retail pharmacy










































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Week of   










































































































































































































































































Week of Mon, Jan 2nd, 2012

Goody elastic accessory sports jewelry look

Goody has unveiled DoubleWear, a collection of multitasking, jewelry-inspired elastics and headwraps.

Sandoz rolls out shampoo for psoriasis

Sandoz has introduced clobetasol propionate shampoo 0.05%, indicated for the treatment of moderate to severe scalp psoriasis.

Paper Mate expands lineup with InkJoy

Newell Rubbermaid has launched of Paper Mate InkJoy, which the company said provides the performance of a premium pen at an everyday price.

Parata Systems sponsors pharmacy conference

Parata Systems will be the exclusive presenting sponsor of the 2012 Independent Pharmacy Business Growth Conference next month in Orlando, Fla.

Prilosec OTC kicks off voting for NFL award

Prilosec OTC, the National Football League and Pro Football Hall of Fame coach John Madden have announced the start of fan voting for the third annual Madden Protectors Award.

Helen of Troy wraps up PUR acquisition

Helen of Troy Ltd. has closed its deal to acquire the PUR water purification product business from Procter & Gamble Co.

Actavis releases generic Clobex products

Actavis Group has started shipping Clobetasol Propionate Shampoo and Clobetasol Propionate Lotion, indicated for the treatment of eczema and psoriasis.

Former Bristol-Myers exec to head Teva

Shlomo Yanai, president and chief executive officer of Teva Pharmaceutical Industries Ltd., plans to retire in May, and the company has named Jeremy Levin, a former senior executive at Bristol-Myers Squibb to succeed him.

Advertisement